Literature DB >> 28355461

Isavuconazole: is there a need for a new antifungal?

Oliver A Cornely1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28355461     DOI： 10.1093/jac/dkx027

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.

Authors:  Mikhail V Keniya; Yasmeen N Ruma; Joel D A Tyndall; Brian C Monk
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 2.  CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors:  Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

3.  Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.

Authors:  Chiara Cattaneo; Alessandro Busca; Doriana Gramegna; Francesca Farina; Anna Candoni; Monica Piedimonte; Nicola Fracchiolla; Chiara Pagani; Maria Ilaria Del Principe; Maria Chiara Tisi; Massimo Offidani; Rosa Fanci; Stelvio Ballanti; Angelica Spolzino; Marianna Criscuolo; Francesco Marchesi; Gianpaolo Nadali; Mario Delia; Marco Picardi; Margherita Sciumé; Valentina Mancini; Attilio Olivieri; Mario Tumbarello; Giuseppe Rossi; Livio Pagano
Journal:  Hemasphere       Date:  2019-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.